Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Inverness is buying HemoSense for $171.6mm in stock

07 Nov 2007

Executive Summary

Inverness Medical Innovations will acquire point-of-care testing company HemoSense for $171.6mm in stock or 10.5 times HemoSense's 2006 revenues.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Hematology, Coagulation
    • Therapeutic Drug Monitoring
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By